Payment overview · 2025
General Payments
$179,687.04
244 reported records · 27 companies
Healthcare provider profile · identity verified
Michael Cyrus Siah
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · DALLAS, TX · NPI 1346668233
Verified facts
What the public records show
CMS Open Payments records show Michael Cyrus Siah received $179,687.04 in general payments during 2025 across 244 reported records.
Stryker Corporation accounted for 53.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 43 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $95,694.33 | 53.3% | 64 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $18,421.35 | 10.2% | 25 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $16,787.83 | 9.3% | 20 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $14,728.96 | 8.2% | 18 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$10,947.04 | 6.1% | 28 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $10,469.45 | 5.8% | 37 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $6,569.63 | 3.7% | 9 | 2025 |
| Cook Incorporated | Unresolved — no canonical attribution shown | $2,550.00 | 1.4% | 1 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $559.37 | 0.3% | 4 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $473.95 | 0.3% | 3 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $406.59 | 0.2% | 5 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $234.58 | 0.1% | 7 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $225.93 | 0.1% | 2 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $225.19 | 0.1% | 3 | 2025 |
| Neuros Medical, Inc. | Unresolved — no canonical attribution shown | $209.13 | 0.1% | 2 | 2025 |
| Nipro Medical Corporation | Unresolved — no canonical attribution shown | $203.81 | 0.1% | 3 | 2025 |
| Rapid Medical Ltd | Unresolved — no canonical attribution shown | $162.50 | 0.1% | 1 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $140.27 | 0.1% | 1 | 2025 |
| Veryan Medical Incorporated | Unresolved — no canonical attribution shown | $131.48 | 0.1% | 1 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $131.00 | 0.1% | 1 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $102.56 | 0.1% | 1 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $82.04 | 0.1% | 3 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $50.00 | 0.0% | 1 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $50.00 | 0.0% | 1 | 2025 |
| Avantec Vascular Corporation | Unresolved — no canonical attribution shown | $46.82 | 0.0% | 1 | 2025 |
| MIMEDX Group, Inc. | Unresolved — no canonical attribution shown | $46.30 | 0.0% | 1 | 2025 |
| ASAHI INTECC USA, INC. | Unresolved — no canonical attribution shown | $36.93 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $113,387.50 | 36 |
| Travel and Lodging | $41,330.54 | 36 |
| Food and Beverage | $10,819.00 | 165 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,300.00 | 3 |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,850.00 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $100,331.47 | 52 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $96,526.37 | 46 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $16,787.83 | 20 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $10,878.96 | 15 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $10,469.45 | 37 | 2025 |
Source payment records
|
|||||
| XIENCE SKYPOINT Normalized: xience skypoint |
Device | Abbott Laboratories | $3,850.00 | 3 | 2025 |
Source payment records
|
|||||
| ZILVER 518 Normalized: zilver 518 |
Device | Cook Incorporated | $2,550.00 | 1 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $1,496.30 | 15 | 2025 |
Source payment records
|
|||||
| IGT Devices Undivided Normalized: igt devices undivided |
Device | Philips North America LLC | $541.93 | 2 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $473.95 | 3 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $436.19 | 6 | 2025 |
Source payment records
|
|||||
| MO.MA ULTRA Normalized: mo ma ultra |
Device | Medtronic, Inc. | $431.42 | 2 | 2025 |
Source payment records
|
|||||
| HAWKONE Normalized: hawkone |
Device | Medtronic, Inc. | $309.04 | 5 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $225.93 | 2 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $225.93 | 2 | 2025 |
Source payment records
|
|||||
| Altius Normalized: altius |
Device | Neuros Medical, Inc. | $209.13 | 2 | 2025 |
Source payment records
|
|||||
| Hemodialysis System Normalized: hemodialysis system |
Device | Nipro Medical Corporation | $203.81 | 3 | 2025 |
Source payment records
|
|||||
| TURBOHAWK Normalized: turbohawk |
Device | Medtronic, Inc. | $194.89 | 2 | 2025 |
Source payment records
|
|||||
| COMANECI 17 Normalized: comaneci 17 |
Device | Rapid Medical Ltd | $162.50 | 1 | 2025 |
Source payment records
|
|||||
| TIGERTRIEVER 17 REVASCULARIZATION DEVICE Normalized: tigertriever 17 revascularization device |
Device | Rapid Medical Ltd | $162.50 | 1 | 2025 |
Source payment records
|
|||||
| PRODIGY CATHETER Normalized: prodigy catheter |
Device | Imperative Care, Inc | $140.27 | 1 | 2025 |
Source payment records
|
|||||
| BioMimics 3D Vascular Stent System Normalized: biomimics 3d vascular stent system |
Device | Veryan Medical Incorporated | $131.48 | 1 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $131.00 | 1 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc. | $119.09 | 4 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $110.90 | 1 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $102.56 | 1 | 2025 |
Source payment records
|
|||||
| COOK Normalized: cook |
Device | Cook Medical LLC | $101.31 | 1 | 2025 |
Source payment records
|
|||||
| EXCLUDER Conformable AAA Endoprosthesis with Active Control Normalized: excluder conformable aaa endoprosthesis with active control |
Device | W. L. Gore & Associates, Inc. | $100.91 | 3 | 2025 |
Source payment records
|
|||||
| IN.PACT ADMIRAL Normalized: in pact admiral |
Device | Medtronic, Inc. | $90.77 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $82.04 | 3 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $82.04 | 3 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $82.04 | 3 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $82.04 | 3 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $82.04 | 3 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $81.71 | 1 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $63.54 | 1 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $50.00 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $50.00 | 1 | 2025 |
Source payment records
|
|||||
| Asahi Peripheral Vascular Wires Normalized: asahi peripheral vascular wires |
Device | ASAHI INTECC USA, INC. | $36.93 | 1 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $34.97 | 1 | 2025 |
Source payment records
|
|||||
| Turbo Power Normalized: turbo power |
Device | Philips North America LLC | $17.44 | 2 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Iliac Branch Endoprosthesis Normalized: gore excluder iliac branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $16.99 | 2 | 2025 |
Source payment records
|
|||||
| ZENITH SPIRAL-Z Normalized: zenith spiral z |
Device | Cook Medical LLC | $12.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 27 | 16 |
| Eliquis | Apixaban | 27 | suppressed |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $179,687.04 · 244 records | Stryker Corporation | ARTIX MT, AURYON LASER SYSTEM 100-120 VAC, Altius, Asahi Peripheral Vascular Wires, BioMimics 3D Vascular Stent System, CGuard Prime Carotid Stent System, COMANECI 17, COOK, CT THROMBECTOMY SYSTEM KIT, ENDOCROSS Device, ENDURANT IIS, ESPRIT, EXCLUDER Conformable AAA Endoprosthesis with Active Control, FLOWTRIEVER CATHETER, S, GORE EXCLUDER Iliac Branch Endoprosthesis, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE VIABAHN VBX Balloon Expandable Endo, HAWKONE, Hemodialysis System, IGT Devices Undivided, IN.PACT ADMIRAL, Indigo System, LIMFLOW SYSTEM, LifeVest, MO.MA ULTRA, PRODIGY CATHETER, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, RotarexS 6 F x 135 cm, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, TIGERTRIEVER 17 REVASCULARIZATION DEVICE, TURBOHAWK, Torus Stent Graft System, Turbo Power, Wegovy, XIENCE SKYPOINT, ZENITH SPIRAL-Z, ZILVER 518, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error